Inferring Dysregulated Pathways of Driving Cancer Subtypes Through Multi-omics Integration
The rapid accumulation of multi-omics cancer data has created the opportunity for biological discovery and biomedical applications. In this study, we propose an approach that integrates multi-omics data to identify dysregulated pathways driving cancer subtypes, which simultaneously considers DNA methylation, DNA copy number, somatic mutation and gene expression profiles. After applying it to Breast Invasive Carcinoma (BRCA) in TCGA, we identify distinct top 30 dysregulated pathways for each breast cancer subtypes. The result suggests that dysregulated pathways of different subtypes display common and specific patterns. Furthermore, 44 differentially expressed genes with corresponding genetic and epigenetic dysregulation are retrieved from the subtype-specific pathways. Literature validation and functional enrichment analysis indicate that these genes are function associated with BRCA. Our method provides a new insight for identifying the driver of cancer subtypes through multi-omics data integration.
KeywordsDysregulated pathways BRCA Data integration Maximum relevance minimum redundancy Disease gene
This work was supported by the National NSFC (Grant No. 61532014 & No. 61432010 & No. 61672407 & No. 61772395), the Fundamental Research Funds for the Central Universities (No. JB150303) and the Fundamental Research Funds for young teacher (2017KY0264).
- 8.Dimitrakopoulos, C.M., Beerenwinkel, N.: Computational approaches for the identification of cancer genes and pathways. Wiley Interdiscip. Rev. Syst. Biol. Med. 9(1) (2017)Google Scholar
- 14.Han, L., Maciejewski, M., Brockel, C., et al.: A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease. Bioinformatics 1, 9 (2017)Google Scholar
- 28.Ouadid-Ahidouch, H., Dhennin-Duthille, I., Gautier, M., et al.: TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters. Bull. Cancer 99(6), 655–664 (2012)Google Scholar
- 30.Troxell, M.L., Levine, J., Beadling, C., et al.: High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod. Pathol. Off. J. U.S. Can. Acad. Pathol. Inc. 23(1), 27–37 (2010)Google Scholar